Page 142 - Bse Sensex

Cyient DLM share slips 12%, hits 52-wk low on weak December quarter results

Going ahead, MOFSL expects the growth momentum to slow down in the near term due to the lack of BEL orders and a delay in order flows from existing and new clients.

Mobile, EMS growth fuels Dixon Technologies stellar Q3; analysts up targets

Dixon Technologies' Mobile and Electronics Manufacturing Services (EMS) division emerged as the primary engine of the company's success during Q3, analysts said.

Stock Market Crash Highlights: Sensex sinks 1,235pts, Nifty ends at 23,024; broader indices bleed 2%

Stock Market Crash Highlights, January 21, 2025: Indian equities faced severe declines on Tuesday with the 30-share BSE Sensex crashing 1235.08 points or 1.60 per cent to settle at 75,838.36

MCX share price slips 11% despite posting strong Q3 show; revenue up 57%

In its Q3, the company swung back to profit at Rs 160.04 crore from a loss of Rs 5.35 crore incurred a year ago

J&K Bank shares slip after posting Q3 results; What's worrying investors?

The net interest income (NII) for the quarter under review stood at Rs 1,509 crore, up 17 per cent, as compared to Rs 1,280 crore a year ago

Indoco Remedies drops 4% on weak Q3 performance; revenue falls 11% YoY

Indoco Remedies share dropped after the company reported a weak set of numbers in the December quarter of financial year 2025 (Q3FY25)

Apollo Hospitals rises 3%; Kotak upgrades to 'Buy' from 'Add', raises TP

As per Kotak Institutional Equities the company's overall bed expansion over FY2025-27E is still much lower than almost all of its peers

Kalyan Jewellers slips 7%, hits 6-mth low; tanks 38% in 13 days; here's why

The company's promoters pledged an additional 36.15 million equity shares or 3.5 per cent of total equity of the company in favor of multiple non banking finance companies and others.

Venus Remedies share price surges 12% on renewal of EU GMP certification

The rise in Venus Remedies share price came after the company announced the renewal of its European GMP certification by Infarmed, the National Authority of Medicines and Health Products in Portugal

This Mukul Agrawal portfolio stock surges 23% in 3 days; hits new high

Mukul Agrawal bought a 1.61% stake in KRN, against nil holding at the end of September quarter, as per the company's December quarter shareholding pattern data

Analysts rule out pre-budget market rally; Trump, Q3FY25 earnings in focus

According to Morgan Stanley, markets seem to be approaching the budget with skepticism and could be dealing with both volatility and upside risk post budget.

Tanla Platforms share price gains 8% ahead of Q3FY25 results annoucement

The software company, in the quarter ended on September 30, 2024, reported a consolidated net profit of Rs 130.2 crore as compared to Rs 142.54 crore in the year-ago period

Glenmark Pharma share rises 2% as unit launches blood clotting drug

The uptick in Glenmark Pharmaceuticals share price came after the company announced the launch of Phytonadione Injectable Emulsion USP, 10 mg/mL Single Dose Ampules

Paytm falls 7% on profit booking post Q3 results; up 161% in past 6 months

Paytm's revenue rose 10.1% sequentially, due to an increase in GMV, a healthy growth in subscription revenues and an increase in revenues from distribution of financial services

Oberoi Realty drops 8% despite posting strong Q3 show; here's why

The company posted a 71.70 per cent year-on-year (Y-o-Y) increase in net profit for the third quarter of FY25 (Q3 FY25), reaching Rs 618.38 crore, compared to Rs 360.15 crore in Q3 FY24

Newgen Software slips 10% post Q3 results; stock down 22% in 4 days

The revenue growth moderation was due to a lower-than-expected revenue realisation from the India business

Stallion India Fluorochemicals IPO allotment: Check status, listing date

Investors can check Stallion India Fluorochemicals' allotment status by visiting NSE, BSE, or its registrar Bigshare Services

Vodafone Idea stocks extend rally on AGR waiver buzz; gain 30% in 1 week

The government is considering a proposal to waive 50% of interest and 100% of penalties and interest on penalties that make up a bulk of the AGR dues levied on telcos

Wipro's Q3FY25 results exceed projections, yet analysts remain divided

Wipro's Q3FY25 net profit rose 24.5 per cent Y-o-Y to Rs 3,350 crore, with a 4.5 per cent Q-o-Q increase. Revenue was Rs 22,320 crore, up 0.5 per cent Y-o-Y and flat Q-o-Q

HUL Q3 preview: Analysts see muted quarter; PAT may rise 2% YoY, revenue 1%

Analysts and investors will eye HUL's outlook on demand and growth